Bioiberica

Manufacturer

Audited

Warning letter

Headquarters

Spain

Sites

Spain

United States of America

Germany

Issue date

30 Jun 2022

Issuing office

Center for Drug Evaluation and Research | CDER

Posted date

19 Jul 2022

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Products & Services

Drugs